Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH possibility

.Novo Nordisk has actually axed its once-monthly double GLP-1/ GIP receptor agonist, finishing (PDF)...

Daiichi pays for Merck $170M to create bronchi cancer cells T-cell engager contract

.Merck &amp Co. has actually rapidly made back some of the costs of its own Harp on Therapies buyout...

BioMarin halts preclinical genetics therapy for heart condition

.After BioMarin performed a spring season well-maintained of its own pipeline in April, the company ...

Eisai plants molecular adhesive SEED with $1.5 B biobucks work

.Huge Pharmas remain caught to the idea of molecular adhesive degraders. The latest business to find...

Life science credit rating firm reveals along with $600M

.A brand-new international life science debt agency, dubbed Symbiotic Funding, has reared more than ...

BMS channels TIGIT, ignoring $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing yet another large wager coming from the Caforio age, ending ...

Nuvation stops BET inhibitor after thinking about stage 1 data

.After checking out at period 1 record, Nuvation Bio has actually made a decision to halt work on it...

' Clinical intuitiveness' led FDA specialists to support Zevra's uncommon ailment med

.Zevra Therapeutics' uncommon disease drug seems to become on the pathway to confirmation this fall ...

Pfizer takes $230M struck after axing fell short DMD genetics treatment

.Pfizer's period 3 Duchenne muscle dystrophy (DMD) gene treatment breakdown has actually gone a $230...

AC Immune sees 'spots' possible in Alzheimer's medication data

.After much more than twenty years of focus on neurodegenerative ailments, Swiss biotech air conditi...